Stock SOLIGENIX INC
Add to a list
To use this feature you must be a member
Log inSign up
Inactive Instrument

Calendar Soligenix Inc OTC Bulletin Board

Equities

US8342232084

End-of-day quote OTC Bulletin Board
Other stock markets
- USD - Intraday chart for Soligenix Inc
25/06 Soligenix, Inc. Announces Positive Clinical Results from A Comparative Study Evaluating Hybryte?? Against Valchlor®? in the Treatment of Cutaneous T-Cell Lymphoma CI
23/05 Sector Update: Health Care Stocks Retreat Late Afternoon MT

Chart calendar Soligenix Inc

83f5753f.p6MqF3ndasgGS5SkJ4Xs5UfwXdfgOoiVhgn_8V_zR2I.7e5MJE6oCIVHe8bPCtCb0wKXMuTNd_78wE-gwTusEAnu6h9eC749m24ZrA~2348af0833c01168bc6765a81173b9e1

Upcoming events on Soligenix Inc

15/08/2024 Q2 2024 Earnings Release (Projected)
13/11/2024 Q3 2024 Earnings Release (Projected)
01/04/2025 Q4 2024 Earnings Release (Projected)

Past events on Soligenix Inc

17/06/2024 06:15 pm American Society of Microbiology Microbe Conference - Axel Lehrer
17/06/2024 05:45 pm American Society of Microbiology Microbe Conference - Panel
06/06/2024 Reverse Split: 1 of 16
30/05/2024 06:30 pm Annual General Meeting - Second Call
23/05/2024 06:30 pm Annual General Meeting - First Call
23/05/2024 07:45 am Vaccine Technology Conference
21/05/2024 Alliance Global Partners Healthcare Showcase
13/05/2024 BioPartnering Conference
10/05/2024 05:00 pm Q1 2024 Earnings Release
07/05/2024 Aegis Virtual Conference
07/05/2024 Aegis Virtual Conference
15/03/2024 05:00 pm Q4 2023 Earnings Release
21/02/2024 RedChip Investor Group Call
30/01/2024 Microcap Conference
25/01/2024 08:00 pm Sequire Investor Summit
15/12/2023 07:30 pm Annual General Meeting
13/11/2023 06:00 pm Q3 2023 Earnings Release
19/10/2023 ThinkEquity Conference
21/08/2023 05:00 pm Q2 2023 Earnings Release
15/05/2023 05:00 pm Q1 2023 Earnings Release

Annual results

Fiscal PeriodDecember 2019 2020 2021 2022 2023 2024
Net sales
Million USD		Released
Forecast
Spread 		4,60
3,79
21.44%		2,40
2,20
9.25%		0,80
0,72
10.42%		0,90
0,79
13.71%		0,84
0,80
5.25%
0,71

EBITDA
Released
Forecast
Spread 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
-
0,00

EBIT
Million USD		Released
Forecast
Spread 		-10,5
-10,0
-4.9%		-13,6
-14,1
3.69%		-13,1
-12,2
-7.64%		-14,2
-13,9
-2.68%		-7,70
-7,44
-3.47%
-8,32

Earnings before Tax (EBT)
Million USD		Released
Forecast
Spread 		-9,97
-9,90
-0.65%		-18,5
-15,4
-19.95%		-13,4
-12,4
-8.19%		-15,0
-14,9
-0.36%		-7,91
-7,50
-5.45%
-8,40

Net income
Million USD		Released
Forecast
Spread 		-9,40
-9,29
-1.19%		-17,7
-14,4
-22.86%		-12,6
-12,2
-2.95%		-13,8
-14,0
1.13%		-6,14
-6,35
3.28%
-8,58

EPS
USD		Released
Forecast
Spread 		-115
-118
2.04%		-154
-128
-19.63%		-74,4
-73,2
-1.64%		-77,0
-76,8
-0.21%		-12,6
-13,2
4.24%
-8,20

Announcement Date30/03/2030/03/2129/03/2231/03/2315/03/24-

Quarterly results

Fiscal PeriodDecember 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1 2025 Q2
Net sales
Million USD		Released
Forecast
Spread 		0,20
0,10
100%		0,40
0,20
100%		0,17
0,20
-16.93%		0,32
0,20
58.58%		0,30
0,20
50%		0,20
0,20
0%		0,13
0,20
-34.78%		0,24
0,20
22.41%		0,10
0,20
-50%
0,20


0,20


0,20







EBIT
Million USD		Released
Forecast
Spread 		-4,20
-2,70
-55.65%		-3,40
-3,56
4.59%		-3,08
-3,42
10.01%		-3,57
-3,18
-12.35%		-2,15
-3,50
38.55%		-1,63
-3,01
45.77%		-1,78
-2,89
38.4%		-2,14
-1,86
-14.97%		-2,12
-2,10
-0.81%
-2,01


-2,11


-2,11







Earnings before Tax (EBT)
Million USD		Released
Forecast
Spread 		-4,35
-2,80
-55.32%		-3,54
-3,10
-14.25%		-3,31
-3,30
-0.27%		-3,75
-3,70
-1.45%		-2,21
-3,60
38.69%		-1,61
-3,90
58.67%		-1,66
-4,30
61.33%		-2,43
-2,00
-21.33%		-1,92
-2,10
8.79%
-2,10


-2,20


-2,20







Net income
Million USD		Released
Forecast
Spread 		-4,30
-2,80
-53.57%		-2,40
-3,72
35.41%		-3,31
-3,58
7.61%		-3,76
-3,34
-12.6%		-1,00
-3,60
72.22%		-1,60
-3,16
49.43%		-1,66
-3,10
46.29%		-1,82
-2,02
9.77%		-1,90
-2,10
9.52%
-2,11


-2,21


-2,21







EPS
USD		Released
Forecast
Spread 		-24,0
-16,8
-42.86%		-14,4
-20,4
29.41%		-19,2
-21,6
11.11%		-19,8
-18,0
-10.22%		-5,76
-20,0
71.2%		-3,52
-6,08
42.11%		-2,56
-4,64
44.83%		-2,56
-3,12
17.95%		-2,88
-3,04
5.26%
-1,78


-1,91


-1,89


-1,76


-1,76

Announcement Date13/05/2212/08/2210/11/2231/03/2315/05/2321/08/2313/11/2315/03/2410/05/24-----

Upcoming sector events for Soligenix Inc

24/07/2024 VIKING THERAPEUTICS, INC.: Q2 2024 Earnings Release (Projected)
25/07/2024 BIOCON LIMITED: Q1 2025 Earnings Release (Projected)
25/07/2024 10:30 am ARGENX SE: Q2 2024 Earnings Release
30/07/2024 RHYTHM PHARMACEUTICALS, INC.: Q2 2024 Earnings Release (Projected)
30/07/2024 NEUROCRINE BIOSCIENCES, INC.: Q2 2024 Earnings Release (Projected)
30/07/2024 CEREVEL THERAPEUTICS HOLDINGS, INC.: Q2 2024 Earnings Release (Projected)
31/07/2024 CASSAVA SCIENCES, INC.: Q2 2024 Earnings Release (Projected)
31/07/2024 SPRINGWORKS THERAPEUTICS, INC.: Q2 2024 Earnings Release (Projected)
31/07/2024 XENCOR, INC.: Q2 2024 Earnings Release (Projected)
31/07/2024 SAREPTA THERAPEUTICS, INC.: Q2 2024 Earnings Release (Projected)
More events

Past sector events for Soligenix Inc

05/06/2024 01:21 pm PHARMAESSENTIA CORPORATION: May 2024 Sales and Revenue Release
17/05/2024 04:30 pm AUTOLUS THERAPEUTICS PLC: Q1 2024 Earnings Release
16/05/2024 05:16 pm BIOCON LIMITED: Q4 2024 Earnings Release
16/05/2024 10:30 am ZEALAND PHARMA A/S: Q1 2024 Earnings Release
16/05/2024 LIGACHEM BIOSCIENCES INC.: Q1 2024 Earnings Release
15/05/2024 05:35 pm THIRD HARMONIC BIO, INC.: Q1 2024 Earnings Release
15/05/2024 04:30 pm CABALETTA BIO, INC.: Q1 2024 Earnings Release
15/05/2024 TAIMED BIOLOGICS INC.: Q1 2024 Earnings Release
15/05/2024 01:35 am ENLIVEN THERAPEUTICS, INC.: Q1 2024 Earnings Release
15/05/2024 01:30 am ARCUTIS BIOTHERAPEUTICS, INC.: Q1 2024 Earnings Release
  1. Stock Market
  2. Equities
  3. SNGX Stock
  4. Stock
  5. Calendar Soligenix Inc